Gene Therapy For Inherited Genetic Disorders Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Gene Therapy For Inherited Genetic Disorders Market Report 2026

Name: Gene Therapy For Inherited Genetic Disorders Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (Viral Vector-Based Therapies, Gene Editing Techniques, Ribonucleic Acid-Based Therapies, Ex Vivo Gene Therapy), By Application (Inherited Metabolic Disorders, Neurological Disorders, Cardiovascular Disorders, Musculoskeletal Disorders, Ophthalmic Disorders), By End-User (Hospitals, Specialty Clinics, Research Institutes, Other End-Users) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Gene Therapy For Inherited Genetic Disorders Market Overview

• Gene Therapy For Inherited Genetic Disorders market size has reached to $4.05 billion in 2025

• Expected to grow to $9.69 billion in 2030 at a compound annual growth rate (CAGR) of 19%

• Growth Driver: Rising Demand For Personalized Medicine Driving Growth In The Market Due To Advancements In Genetic Technologies

• Market Trend: One-Time CRISPR-Edited Cell Therapies Transforming Treatment Of Inherited Genetic Disorders

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Gene Therapy For Inherited Genetic Disorders Market?

Gene therapy for inherited genetic disorders is a medical strategy that targets the root cause of hereditary diseases by repairing or replacing faulty genes. Its main goal is to provide a potential cure rather than merely alleviating symptoms. It introduces functional genes into a patient’s cells, restores normal cell function, and improves overall health. This approach shows significant promise for treating rare genetic disorders, offering the possibility of long-lasting or permanent therapeutic effects.

The main types of gene therapy for inherited genetic disorders are viral vector-based therapies, gene editing techniques, ribonucleic acid-based therapies, and ex vivo gene therapy. Viral vector-based therapies use genetically modified, non-replicating viruses to deliver therapeutic genetic material into patient cells for treating diseases. These therapies are applied in various applications such as inherited metabolic disorders, neurological disorders, cardiovascular disorders, musculoskeletal disorders, and ophthalmic disorders and used by several end users, including hospitals, specialty clinics, research institutes, and others.

Gene Therapy For Inherited Genetic Disorders Market Global Report 2026 Market Report bar graph

What Is The Gene Therapy For Inherited Genetic Disorders Market Size and Share 2026?

The gene therapy for inherited genetic disorders market size has grown rapidly in recent years. It will grow from $4.05 billion in 2025 to $4.84 billion in 2026 at a compound annual growth rate (CAGR) of 19.3%. The growth in the historic period can be attributed to limited availability of advanced gene therapy techniques, reliance on conventional treatments for genetic disorders, increasing prevalence of inherited genetic diseases, early clinical research on viral vectors, rising awareness of rare disease management.

What Is The Gene Therapy For Inherited Genetic Disorders Market Growth Forecast?

The gene therapy for inherited genetic disorders market size is expected to see rapid growth in the next few years. It will grow to $9.69 billion in 2030 at a compound annual growth rate (CAGR) of 19.0%. The growth in the forecast period can be attributed to development of novel viral vectors and gene editing technologies, expansion of rna-based therapies, increasing adoption of ex vivo stem cell therapies, rising investment in personalized gene therapies, growth in hospital and specialty clinic capabilities for gene therapy administration. Major trends in the forecast period include expansion of viral vector-based therapies for rare genetic disorders, growth in ex vivo gene therapy applications, increasing adoption of rna-based therapeutics, rising focus on treating neurological and ophthalmic disorders, integration of personalized medicine in gene therapy.

Book your 30 minutes free consultation with our research experts

Global Gene Therapy For Inherited Genetic Disorders Market Segmentation

1) By Type: Viral Vector-Based Therapies, Gene Editing Techniques, Ribonucleic Acid-Based Therapies, Ex Vivo Gene Therapy

2) By Application: Inherited Metabolic Disorders, Neurological Disorders, Cardiovascular Disorders, Musculoskeletal Disorders, Ophthalmic Disorders

3) By End-User: Hospitals, Specialty Clinics, Research Institutes, Other End-Users

Subsegments:

1) By Viral Vector-Based Therapies: Adenovirus Vectors, Adeno-Associated Virus (AAV) Vectors, Lentivirus Vectors

2) By Gene Editing Techniques: Zinc Finger Nucleases (ZFNs), Transcription Activator-Like Effector Nucleases (TALENs), Meganucleases

3) By Ribonucleic Acid-Based Therapies: Small Interfering Ribonucleic Acid, Antisense Oligonucleotides (ASOs), Messenger Ribonucleic Acid (mRNA) Therapies

4) By Ex Vivo Gene Therapy: Hematopoietic Stem Cell Gene Therapy, Mesenchymal Stem Cell Gene Therapy, Induced Pluripotent Stem Cell (iPSC) Therapy

What Is The Driver Of The Gene Therapy For Inherited Genetic Disorders Market?

The rising demand for personalized medicine is expected to propel the growth of the gene therapy for inherited genetic disorders market going forward. Personalized medicine refers to tailoring medical treatment to an individual’s genetic profile and personal characteristics for optimized care. Personalized medicine is increasing due to advancements in genetic technologies, making it easier and more affordable to tailor treatments to an individual’s unique genetic makeup. Personalized medicine boosts gene therapy by customizing treatments to each patient’s unique genetic profile, ensuring precise gene targeting and delivery while enhancing effectiveness and reducing side effects. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the United States Food and Drug Administration (FDA) approved 16 new personalized treatments for rare disease patients, up from 6 in 2022. The newly approved personalized treatments for 2023 also include seven cancer drugs and three for other diseases and conditions. Therefore, the rising demand for personalized medicine is driving the growth of the gene therapy for inherited genetic disorders industry.

Key Players In The Global Gene Therapy For Inherited Genetic Disorders Market

Major companies operating in the gene therapy for inherited genetic disorders market are Sanofi S.A., Novartis AG, Astellas Pharma Inc., Vertex Pharmaceuticals Incorporated, Genentech, Biomarin Pharmaceutical Inc, Sarepta Therapeutics Inc., Krystal Biotech Inc., Rocket Pharmaceuticals Inc., Sangamo Therapeutics Inc., REGENXBIO Inc., Passage Bio Inc., Voyager Therapeutics Inc., Generation Bio Co., Avrobio Inc, Editas Medicine Inc., MeiraGTx Holdings Plc, uniQure N.V., Intellia Therapeutics Inc., Bluebird Bio Inc, 4D Molecular Therapeutics Inc., CRISPR Therapeutics AG

Global Gene Therapy For Inherited Genetic Disorders Market Trends and Insights

Major companies operating in the gene therapy for inherited genetic disorders market are focusing on developing innovative solutions, such as ex-vivo CRISPR/Cas9-based gene-edited cell therapies, to meet the rising demand for one-time, potentially curative treatments that reduce lifelong dependence on transfusions, repeated hospitalizations, and high chronic-care costs for inherited blood and metabolic disorders. Ex-vivo CRISPR/Cas9 gene-edited cell therapy involves harvesting a patient’s hematopoietic stem cells, using CRISPR/Cas9 to precisely edit disease-causing genes (or regulatory elements that increase protective fetal hemoglobin), and then reinfusing the modified cells so they engraft and provide long-term therapeutic benefit. For instance, in December 2023, Vertex Pharmaceuticals, a US-based biopharmaceutical company, received U.S. Food and Drug Administration (FDA) approval and commercial availability of CASGEVY (exagamglogene autotemcel), a CRISPR/Cas9-based, ex-vivo gene-edited cell therapy for sickle cell disease (an inherited genetic disorder). CASGEVY is manufactured from a patient’s own hematopoietic stem cells that are gene edited to increase fetal hemoglobin: the product’s composition centers on autologous stem cells modified with CRISPR/Cas9; its functionality is to raise durable fetal hemoglobin levels that prevent red-blood-cell sickling; unique features include precise genome editing (CRISPR/Cas9) performed ex vivo and a one-time administration with durable effect; its primary application is treating severe sickle cell disease (and related indications under regulatory review), and the main benefits observed in trials are marked reductions in vaso-occlusive crises and transfusion dependence compared with prior standard-of-care.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Gene Therapy For Inherited Genetic Disorders Market?

In October 2024, Ocuphire Pharma Inc., a US-based biotechnology company, acquired Opus Genetics Inc. for an undisclosed amount. With this acquisition, Ocuphire Pharma aims to become a leader in developing and advancing gene therapies for rare inherited retinal diseases by combining Opus's innovative pipeline with its own development expertise. Opus Genetics Inc. is a US-based biotechnology company that offers gene therapy for inherited genetic disorders.

Regional Insights

North America was the largest region in the gene therapy for inherited genetic disorders market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Gene Therapy For Inherited Genetic Disorders Market?

The gene therapy for inherited genetic disorders market consists of revenues earned by entities by providing services such as genetic testing and diagnosis, personalized treatment planning, and gene delivery and administration. The market value includes the value of related goods sold by the service provider or included within the service offering. The gene therapy for inherited genetic disorders market also includes sales of zolgensma, luxturna, and strimvelis. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Gene Therapy For Inherited Genetic Disorders Market Report 2026?

The gene therapy for inherited genetic disorders market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the gene therapy for inherited genetic disorders industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Gene Therapy For Inherited Genetic Disorders Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$4.84 billion
Revenue Forecast In 2035	$9.69 billion
Growth Rate	CAGR of 19.3% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Application, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Sanofi S.A., Novartis AG, Astellas Pharma Inc., Vertex Pharmaceuticals Incorporated, Genentech, Biomarin Pharmaceutical Inc, Sarepta Therapeutics Inc., Krystal Biotech Inc., Rocket Pharmaceuticals Inc., Sangamo Therapeutics Inc., REGENXBIO Inc., Passage
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Gene Therapy For Inherited Genetic Disorders Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Gene Therapy For Inherited Genetic Disorders Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Gene Therapy For Inherited Genetic Disorders Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Gene Therapy For Inherited Genetic Disorders Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Expansion Of Viral Vector-Based Therapies For Rare Genetic Disorders

4.2.2 Growth In Ex Vivo Gene Therapy Applications

4.2.3 Increasing Adoption Of Rna-Based Therapeutics

4.2.4 Rising Focus On Treating Neurological And Ophthalmic Disorders

4.2.5 Integration Of Personalized Medicine In Gene Therapy

5. Gene Therapy For Inherited Genetic Disorders Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Research Institutes

5.4 Gene Therapy Centers

5.5 Academic And Biotech Research Laboratories

6. Gene Therapy For Inherited Genetic Disorders Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Gene Therapy For Inherited Genetic Disorders Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Gene Therapy For Inherited Genetic Disorders PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Gene Therapy For Inherited Genetic Disorders Market Size, Comparisons And Growth Rate Analysis

7.3. Global Gene Therapy For Inherited Genetic Disorders Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Gene Therapy For Inherited Genetic Disorders Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Gene Therapy For Inherited Genetic Disorders Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Gene Therapy For Inherited Genetic Disorders Market Segmentation

9.1. Global Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Viral Vector-Based Therapies, Gene Editing Techniques, Ribonucleic Acid-Based Therapies, Ex Vivo Gene Therapy

9.2. Global Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Inherited Metabolic Disorders, Neurological Disorders, Cardiovascular Disorders, Musculoskeletal Disorders, Ophthalmic Disorders

9.3. Global Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Specialty Clinics, Research Institutes, Other End-Users

9.4. Global Gene Therapy For Inherited Genetic Disorders Market, Sub-Segmentation Of Viral Vector-Based Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adenovirus Vectors, Adeno-Associated Virus (AAV) Vectors, Lentivirus Vectors

9.5. Global Gene Therapy For Inherited Genetic Disorders Market, Sub-Segmentation Of Gene Editing Techniques, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Zinc Finger Nucleases (ZFNs), Transcription Activator-Like Effector Nucleases (TALENs), Meganucleases

9.6. Global Gene Therapy For Inherited Genetic Disorders Market, Sub-Segmentation Of Ribonucleic Acid-Based Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Small Interfering Ribonucleic Acid, Antisense Oligonucleotides (ASOs), Messenger Ribonucleic Acid (mRNA) Therapies

9.7. Global Gene Therapy For Inherited Genetic Disorders Market, Sub-Segmentation Of Ex Vivo Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hematopoietic Stem Cell Gene Therapy, Mesenchymal Stem Cell Gene Therapy, Induced Pluripotent Stem Cell (iPSC) Therapy

10. Gene Therapy For Inherited Genetic Disorders Market Regional And Country Analysis

10.1. Global Gene Therapy For Inherited Genetic Disorders Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Gene Therapy For Inherited Genetic Disorders Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Gene Therapy For Inherited Genetic Disorders Market

11.1. Asia-Pacific Gene Therapy For Inherited Genetic Disorders Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Gene Therapy For Inherited Genetic Disorders Market

12.1. China Gene Therapy For Inherited Genetic Disorders Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Gene Therapy For Inherited Genetic Disorders Market

13.1. India Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Gene Therapy For Inherited Genetic Disorders Market

14.1. Japan Gene Therapy For Inherited Genetic Disorders Market Overview

14.2. Japan Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Gene Therapy For Inherited Genetic Disorders Market

15.1. Australia Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Gene Therapy For Inherited Genetic Disorders Market

16.1. Indonesia Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Gene Therapy For Inherited Genetic Disorders Market

17.1. South Korea Gene Therapy For Inherited Genetic Disorders Market Overview

17.2. South Korea Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Gene Therapy For Inherited Genetic Disorders Market

18.1. Taiwan Gene Therapy For Inherited Genetic Disorders Market Overview

18.2. Taiwan Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Gene Therapy For Inherited Genetic Disorders Market

19.1. South East Asia Gene Therapy For Inherited Genetic Disorders Market Overview

19.2. South East Asia Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Gene Therapy For Inherited Genetic Disorders Market

20.1. Western Europe Gene Therapy For Inherited Genetic Disorders Market Overview

20.2. Western Europe Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Gene Therapy For Inherited Genetic Disorders Market

21.1. UK Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Gene Therapy For Inherited Genetic Disorders Market

22.1. Germany Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Gene Therapy For Inherited Genetic Disorders Market

23.1. France Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Gene Therapy For Inherited Genetic Disorders Market

24.1. Italy Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Gene Therapy For Inherited Genetic Disorders Market

25.1. Spain Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Gene Therapy For Inherited Genetic Disorders Market

26.1. Eastern Europe Gene Therapy For Inherited Genetic Disorders Market Overview

26.2. Eastern Europe Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Gene Therapy For Inherited Genetic Disorders Market

27.1. Russia Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Gene Therapy For Inherited Genetic Disorders Market

28.1. North America Gene Therapy For Inherited Genetic Disorders Market Overview

28.2. North America Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Gene Therapy For Inherited Genetic Disorders Market

29.1. USA Gene Therapy For Inherited Genetic Disorders Market Overview

29.2. USA Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Gene Therapy For Inherited Genetic Disorders Market

30.1. Canada Gene Therapy For Inherited Genetic Disorders Market Overview

30.2. Canada Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Gene Therapy For Inherited Genetic Disorders Market

31.1. South America Gene Therapy For Inherited Genetic Disorders Market Overview

31.2. South America Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Gene Therapy For Inherited Genetic Disorders Market

32.1. Brazil Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Gene Therapy For Inherited Genetic Disorders Market

33.1. Middle East Gene Therapy For Inherited Genetic Disorders Market Overview

33.2. Middle East Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Gene Therapy For Inherited Genetic Disorders Market

34.1. Africa Gene Therapy For Inherited Genetic Disorders Market Overview

34.2. Africa Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Gene Therapy For Inherited Genetic Disorders Market Regulatory and Investment Landscape

36. Gene Therapy For Inherited Genetic Disorders Market Competitive Landscape And Company Profiles

36.1. Gene Therapy For Inherited Genetic Disorders Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Gene Therapy For Inherited Genetic Disorders Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Gene Therapy For Inherited Genetic Disorders Market Company Profiles

36.3.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Vertex Pharmaceuticals Incorporated Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Genentech Overview, Products and Services, Strategy and Financial Analysis

37. Gene Therapy For Inherited Genetic Disorders Market Other Major And Innovative Companies

Biomarin Pharmaceutical Inc, Sarepta Therapeutics Inc., Krystal Biotech Inc., Rocket Pharmaceuticals Inc., Sangamo Therapeutics Inc., REGENXBIO Inc., Passage Bio Inc., Voyager Therapeutics Inc., Generation Bio Co., Avrobio Inc, Editas Medicine Inc., MeiraGTx Holdings Plc, uniQure N.V., Intellia Therapeutics Inc., Bluebird Bio Inc

38. Global Gene Therapy For Inherited Genetic Disorders Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Gene Therapy For Inherited Genetic Disorders Market

40. Gene Therapy For Inherited Genetic Disorders Market High Potential Countries, Segments and Strategies

40.1 Gene Therapy For Inherited Genetic Disorders Market In 2030 - Countries Offering Most New Opportunities

40.2 Gene Therapy For Inherited Genetic Disorders Market In 2030 - Segments Offering Most New Opportunities

40.3 Gene Therapy For Inherited Genetic Disorders Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Gene Therapy For Inherited Genetic Disorders Market, Overview Of Key Products - Product Examples

Table 2: Global Gene Therapy For Inherited Genetic Disorders Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Gene Therapy For Inherited Genetic Disorders Market, Supply Chain Analysis

Table 4: Global Gene Therapy For Inherited Genetic Disorders Market, Major Raw Material Providers

Table 5: Global Gene Therapy For Inherited Genetic Disorders Market, Major Resource Providers

Table 6: Global Gene Therapy For Inherited Genetic Disorders Market, Major Manufacturers (Suppliers)

Table 7: Global Gene Therapy For Inherited Genetic Disorders Market, Major Distributors And Channel Partners

Table 8: Global Gene Therapy For Inherited Genetic Disorders Market, Key Technologies & Future Trends

Table 9: Global Gene Therapy For Inherited Genetic Disorders Market, Major Trends

Table 10: Global Gene Therapy For Inherited Genetic Disorders Market, Major End Users

Table 11: Global Gene Therapy For Inherited Genetic Disorders Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Gene Therapy For Inherited Genetic Disorders Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Gene Therapy For Inherited Genetic Disorders Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Gene Therapy For Inherited Genetic Disorders Market - TAM, US$ Billion, 2025

Table 15: Global Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Gene Therapy For Inherited Genetic Disorders Market, Sub-Segmentation Of Viral Vector-Based Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Gene Therapy For Inherited Genetic Disorders Market, Sub-Segmentation Of Gene Editing Techniques, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Gene Therapy For Inherited Genetic Disorders Market, Sub-Segmentation Of Ribonucleic Acid-Based Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Gene Therapy For Inherited Genetic Disorders Market, Sub-Segmentation Of Ex Vivo Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Gene Therapy For Inherited Genetic Disorders Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Gene Therapy For Inherited Genetic Disorders Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Gene Therapy For Inherited Genetic Disorders Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Gene Therapy For Inherited Genetic Disorders Market - Company Scoring Matrix

Table 98: Sanofi S.A. Financial Performance

Table 99: Novartis AG Financial Performance

Table 100: Astellas Pharma Inc. Financial Performance

Table 101: Vertex Pharmaceuticals Incorporated Financial Performance

Table 102: Genentech Financial Performance

Table 103: Global Gene Therapy For Inherited Genetic Disorders Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Gene Therapy For Inherited Genetic Disorders Market, Competitive Dashboard

Table 105: Global Gene Therapy For Inherited Genetic Disorders Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Gene Therapy For Inherited Genetic Disorders Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 107: Global, Gene Therapy For Inherited Genetic Disorders Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Table 108: Global, Gene Therapy For Inherited Genetic Disorders Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

List Of Figures

Figure 1: Global Gene Therapy For Inherited Genetic Disorders Market, Overview Of Key Products - Product Examples

Figure 2: Global Gene Therapy For Inherited Genetic Disorders Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Gene Therapy For Inherited Genetic Disorders Market, Supply Chain Analysis

Figure 4: Global Gene Therapy For Inherited Genetic Disorders Market, Major Raw Material Providers

Figure 5: Global Gene Therapy For Inherited Genetic Disorders Market, Major Resource Providers

Figure 6: Global Gene Therapy For Inherited Genetic Disorders Market, Major Manufacturers (Suppliers)

Figure 7: Global Gene Therapy For Inherited Genetic Disorders Market, Major Distributors And Channel Partners

Figure 8: Global Gene Therapy For Inherited Genetic Disorders Market, Key Technologies & Future Trends

Figure 9: Global Gene Therapy For Inherited Genetic Disorders Market, Major Trends

Figure 10: Global Gene Therapy For Inherited Genetic Disorders Market, Major End Users

Figure 11: Global Gene Therapy For Inherited Genetic Disorders Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Gene Therapy For Inherited Genetic Disorders Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Gene Therapy For Inherited Genetic Disorders Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Gene Therapy For Inherited Genetic Disorders Market - TAM, US$ Billion, 2025

Figure 15: Global Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Gene Therapy For Inherited Genetic Disorders Market, Sub-Segmentation Of Viral Vector-Based Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Gene Therapy For Inherited Genetic Disorders Market, Sub-Segmentation Of Gene Editing Techniques, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Gene Therapy For Inherited Genetic Disorders Market, Sub-Segmentation Of Ribonucleic Acid-Based Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Gene Therapy For Inherited Genetic Disorders Market, Sub-Segmentation Of Ex Vivo Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Gene Therapy For Inherited Genetic Disorders Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Gene Therapy For Inherited Genetic Disorders Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Gene Therapy For Inherited Genetic Disorders Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Gene Therapy For Inherited Genetic Disorders Market - Company Scoring Matrix

Figure 98: Sanofi S.A. Financial Performance

Figure 99: Novartis AG Financial Performance

Figure 100: Astellas Pharma Inc. Financial Performance

Figure 101: Vertex Pharmaceuticals Incorporated Financial Performance

Figure 102: Genentech Financial Performance

Figure 103: Global Gene Therapy For Inherited Genetic Disorders Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Gene Therapy For Inherited Genetic Disorders Market, Competitive Dashboard

Figure 105: Global Gene Therapy For Inherited Genetic Disorders Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Gene Therapy For Inherited Genetic Disorders Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 107: Global, Gene Therapy For Inherited Genetic Disorders Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Figure 108: Global, Gene Therapy For Inherited Genetic Disorders Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Asphalt Pavers Market Report 2026 - Global Outlook – By Type (Track Pavers, Wheel Pavers, Screeds), By Paving Width (Less Than 2.5 Meters, 2.5 - 5 Meters, More Than 5 Meters), By Technology (Hydrostatic, Mechanical) – Ma...

Asphalt Additives Market Report 2026 - Global Outlook – By Type (Polymeric Modifiers, Anti-strip And Adhesion Promoters, Emulsifiers, Chemical Modifiers, Rejuvenators, Fibers, Flux Oil, Colored Asphalt ), By Technology (...

Plumbing Fixtures and Fittings Market Report 2026 - Global Outlook – By Product (Bathtub, Sinks, Toilets, Showers, Taps, Drains), By Distribution (Online, Offline), By Application (New Construction, Repair And Remodel), ...

Asphalt Pavers Market Report 2026 - Global Outlook – By Type (Track Pavers, Wheel Pavers, Screeds), By Paving Width (Less Than 2.5 Meters, 2.5 - 5 Meters, More Than 5 Meters), By Technology (Hydrostatic, Mechanical) – Ma...

Cognitive Assessment And Training Market Report 2026 - Global Outlook – By Component (Solutions, Services), By Organization Size (Small And Medium-sized Enterprises (Smes), Large Enterprises), By Vertical (Healthcare And...

Asphalt, Lubricating Oil And Grease Market Report 2026 - Global Outlook – By Type (Asphalt, Other Petroleum Products), By Application (Roadways, Waterproofing, Industrial And Construction Applications, Other Applications...

Frequently Asked Questions

How big is the Gene Therapy For Inherited Genetic Disorders Market?

The Gene Therapy For Inherited Genetic Disorders market was valued at $4.05 billion in 2025, increased to $4.84 billion in 2026, and is projected to reach $9.69 billion by 2030.

What is the Gene Therapy For Inherited Genetic Disorders market growth?

The global Gene Therapy For Inherited Genetic Disorders market is expected to grow at a CAGR of 19.0% from 2026 to 2035 to reach $9.69 billion by 2035.

Who are the key players in Gene Therapy For Inherited Genetic Disorders market?

Some Key Players in the Gene Therapy For Inherited Genetic Disorders market Include, Sanofi S.A., Novartis AG, Astellas Pharma Inc., Vertex Pharmaceuticals Incorporated, Genentech, Biomarin Pharmaceutical Inc, Sarepta Therapeutics Inc., Krystal Biotech Inc., Rocket Pharmaceuticals Inc., Sangamo Therapeutics Inc., REGENXBIO Inc., Passage Bio Inc., Voyager Therapeutics Inc., Generation Bio Co., Avrobio Inc, Editas Medicine Inc., MeiraGTx Holdings Plc, uniQure N.V., Intellia Therapeutics Inc., Bluebird Bio Inc, 4D Molecular Therapeutics Inc., CRISPR Therapeutics AG .

What is the anticipated growth trend for the Gene Therapy For Inherited Genetic Disorders market?

Major trend in this market includes: One-Time CRISPR-Edited Cell Therapies Transforming Treatment Of Inherited Genetic Disorders. For further insights on this market. request a sample here

Which region has the most growth potential in the Gene Therapy For Inherited Genetic Disorders market?

North America was the largest region in the gene therapy for inherited genetic disorders market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene therapy for inherited genetic disorders market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.